位置:首页 > 蛋白库 > COAX_PSEAE
COAX_PSEAE
ID   COAX_PSEAE              Reviewed;         248 AA.
AC   Q9HWC1;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 115.
DE   RecName: Full=Type III pantothenate kinase;
DE            EC=2.7.1.33 {ECO:0000269|PubMed:16905099};
DE   AltName: Full=PanK-III;
DE   AltName: Full=Pantothenic acid kinase;
GN   Name=coaX; Synonyms=coaA; OrderedLocusNames=PA4279;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF APOPROTEIN AND COMPLEX WITH
RP   SUBSTRATE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, KINETIC
RP   PARAMETERS, AND MUTAGENESIS OF ASN-9; LYS-13; ASP-101; ASP-121; HIS-156 AND
RP   THR-157.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=16905099; DOI=10.1016/j.str.2006.06.008;
RA   Hong B.S., Yun M.K., Zhang Y.-M., Chohnan S., Rock C.O., White S.W.,
RA   Jackowski S., Park H.-W., Leonardi R.;
RT   "Prokaryotic type II and type III pantothenate kinases: the same monomer
RT   fold creates dimers with distinct catalytic properties.";
RL   Structure 14:1251-1261(2006).
CC   -!- FUNCTION: Catalyzes the phosphorylation of pantothenate (Pan), the
CC       first step in CoA biosynthesis. Can utilize a wide range of phosphoryl
CC       donors other than ATP, and does not discriminate between purine- and
CC       pyrimidine-based nucleotides or deoxynucleotides. Is responsible for
CC       the resistance of P.aeruginosa to the pantothenamide antibiotics, since
CC       it cannot bind and phosphorylate these pantothenate analogs.
CC       {ECO:0000269|PubMed:16905099}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-pantothenate + ATP = (R)-4'-phosphopantothenate + ADP +
CC         H(+); Xref=Rhea:RHEA:16373, ChEBI:CHEBI:10986, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29032, ChEBI:CHEBI:30616, ChEBI:CHEBI:456216;
CC         EC=2.7.1.33; Evidence={ECO:0000269|PubMed:16905099};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:16905099};
CC       Name=NH4(+); Xref=ChEBI:CHEBI:28938;
CC         Evidence={ECO:0000269|PubMed:16905099};
CC       Note=Monovalent cations. Strong preference for ammonium over potassium.
CC       {ECO:0000269|PubMed:16905099};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=14 uM for pantothenate (in the absence of ammonium)
CC         {ECO:0000269|PubMed:16905099};
CC         KM=20 uM for pantothenate (in the presence of ammonium)
CC         {ECO:0000269|PubMed:16905099};
CC         KM=7.2 mM for ATP (in the absence of ammonium)
CC         {ECO:0000269|PubMed:16905099};
CC         KM=3.2 mM for ATP (in the presence of ammonium)
CC         {ECO:0000269|PubMed:16905099};
CC         Note=kcat is 12.5 min(-1) for the phosphorylation of pantothenate in
CC         the absence of ammonium. kcat is 25 min(-1) for the phosphorylation
CC         of pantothenate in the presence of ammonium.
CC         {ECO:0000269|PubMed:16905099};
CC   -!- PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-
CC       pantothenate: step 1/5.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16905099}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the type III pantothenate kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG07667.1; -; Genomic_DNA.
DR   PIR; H83111; H83111.
DR   RefSeq; NP_252969.1; NC_002516.2.
DR   RefSeq; WP_003093768.1; NZ_QZGE01000028.1.
DR   PDB; 2F9T; X-ray; 2.20 A; A/B=1-248.
DR   PDB; 2F9W; X-ray; 1.90 A; A/B=1-248.
DR   PDBsum; 2F9T; -.
DR   PDBsum; 2F9W; -.
DR   AlphaFoldDB; Q9HWC1; -.
DR   SMR; Q9HWC1; -.
DR   STRING; 287.DR97_3628; -.
DR   ChEMBL; CHEMBL4295625; -.
DR   PaxDb; Q9HWC1; -.
DR   PRIDE; Q9HWC1; -.
DR   DNASU; 881667; -.
DR   EnsemblBacteria; AAG07667; AAG07667; PA4279.
DR   GeneID; 881667; -.
DR   KEGG; pae:PA4279; -.
DR   PATRIC; fig|208964.12.peg.4480; -.
DR   PseudoCAP; PA4279; -.
DR   HOGENOM; CLU_066627_0_1_6; -.
DR   InParanoid; Q9HWC1; -.
DR   OMA; NSFIKWR; -.
DR   PhylomeDB; Q9HWC1; -.
DR   BioCyc; PAER208964:G1FZ6-4358-MON; -.
DR   BRENDA; 2.7.1.33; 5087.
DR   UniPathway; UPA00241; UER00352.
DR   EvolutionaryTrace; Q9HWC1; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004594; F:pantothenate kinase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0015937; P:coenzyme A biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   HAMAP; MF_01274; Pantothen_kinase_3; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR004619; Type_III_PanK.
DR   PANTHER; PTHR34265; PTHR34265; 1.
DR   Pfam; PF03309; Pan_kinase; 1.
DR   SUPFAM; SSF53067; SSF53067; 2.
DR   TIGRFAMs; TIGR00671; baf; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; ATP-binding; Coenzyme A biosynthesis;
KW   Cytoplasm; Kinase; Metal-binding; Nucleotide-binding; Potassium;
KW   Reference proteome; Transferase.
FT   CHAIN           1..248
FT                   /note="Type III pantothenate kinase"
FT                   /id="PRO_0000267575"
FT   ACT_SITE        101
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255"
FT   BINDING         6..13
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         92
FT                   /ligand="substrate"
FT   BINDING         99..102
FT                   /ligand="substrate"
FT   BINDING         121
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000305|PubMed:16905099"
FT   BINDING         124
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   BINDING         180
FT                   /ligand="substrate"
FT   MUTAGEN         9
FT                   /note="N->G: 96-fold reduction in activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   MUTAGEN         13
FT                   /note="K->A: 7-fold reduction in activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   MUTAGEN         101
FT                   /note="D->A: 5-fold reduction in activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   MUTAGEN         121
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   MUTAGEN         156
FT                   /note="H->A: No change in activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   MUTAGEN         157
FT                   /note="T->A: 2.5-fold reduction in activity."
FT                   /evidence="ECO:0000269|PubMed:16905099"
FT   STRAND          1..7
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          12..18
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   TURN            19..21
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          22..31
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           32..41
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          47..54
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           58..71
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          92..94
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           100..113
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          117..131
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          135..144
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           146..156
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           164..170
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          177..179
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           180..207
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:2F9W"
FT   HELIX           236..244
FT                   /evidence="ECO:0007829|PDB:2F9W"
SQ   SEQUENCE   248 AA;  26758 MW;  609D37480899DA3B CRC64;
     MILELDCGNS LIKWRVIEGA ARSVAGGLAE SDDALVEQLT SQQALPVRAC RLVSVRSEQE
     TSQLVARLEQ LFPVSALVAS SGKQLAGVRN GYLDYQRLGL DRWLALVAAH HLAKKACLVI
     DLGTAVTSDL VAADGVHLGG YICPGMTLMR SQLRTHTRRI RYDDAEARRA LASLQPGQAT
     AEAVERGCLL MLRGFVREQY AMACELLGPD CEIFLTGGDA ELVRDELAGA RIMPDLVFVG
     LALACPIE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024